Neogen Corporation (NEOG, Financial) experienced a sudden stock price drop of 5.03%, settling at $14.92 per share. This movement came with a trading volume of 355,098 shares, a turnover rate of 0.16%, and a price fluctuation of 4.77%.
Recently released financial data revealed that Neogen's revenue reached $924 million. However, the company reported a net loss of $9.42 million, resulting in earnings per share of -$0.04. The gross profit was reported at $463 million, with a negative price-to-earnings ratio of -373.00.
In terms of stock ratings, out of three financial institutions covering the stock, 67% recommended buying, while 33% suggested holding, and none advised selling.
Within the life sciences industry, where Neogen Corporation operates, the sector saw an overall decline of 1.72%. Notably, stocks like Volitionrx Limited, Check-Cap Ltd., and Ispecimen Inc. recorded significant gains. Additionally, Applied Dna Sciences, Inc., Ispecimen Inc., and Endra Life Sciences Inc. were actively traded with turnover rates of 35.78%, 15.04%, and 2.09% respectively. Volitionrx Limited, Burning Rock Biotech, and Prenetics Global Limited C/Wts 18/05/2027 (To Pur Com) exhibited notable price fluctuations of 20.14%, 13.41%, and 12.17% respectively.
Neogen Corporation, based in Lansing, Michigan, focuses on developing, manufacturing, and selling products for food and animal safety. The company provides diagnostics for food and feed processing entities to detect pathogens, allergens, and drug residues. Additionally, Neogen offers veterinary instruments, medications, disinfectants, and genomic testing services for animals, primarily in the U.S., with operations also in the U.K. and other countries.
